Greater tolerance: Allergic reactions to COVID vaccine lower for second dose
Researchers discovered that recipients experiencing an allergic response to second COVID vaccine dose are minimal
Read More
Author: John Pinching
Haleon days: GSK explains demerger decision
New company Haleon will become standalone venture as GSK’s strategy for the future unfolds
Read More
Victory Road: NHS successful in 11 year claim against Servier
The European Commission finds that Servier committed a breach of competition over blood pressure drug
Read More
PANORAMIC view of World’s largest COVID study
Study involving 10,000 patients will investigate a range of potentially ground-breaking oral antivirals
Read More
Data day: Trial results deliver hope for prostate cancer patients
New combination treatment can significantly reduce the risk of death among prostate cancer patients
Read More- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
